PLX3397 KIT in Acral aNd mucOsal Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

March 2, 2021

Study Completion Date

March 2, 2021

Conditions
Malignant Melanoma
Interventions
DRUG

PLX3397

PLX3397 capsules 1000mg/day as monotherapy

Trial Locations (8)

M20 4BX

The Christie NHS Foundation Trust, Manchester

G12 OXH

The Beatson West of Scotland Cancer Centre, Glasgow

SA2 8QA

Abertawe Bro Morgannwg University Health Board, Singleton Hospital, Swansea

LS9 7TF

St James' University Hospital, Leeds

S10 2SJ

Cancer Clinical Trials Centre- Weston Park Hospital, Sheffield

CB2 0QQ

Cambridge University Hospitals NHS FT - Addenbrookes Hospital, Cambridge

SW3 6JJ

The Royal Marsden NHS Foundation Trust, London

OX3 7LE

Oxford University Hospitals NHS Trust- Churchill Hospital, Oxford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cancer Research UK

OTHER

collaborator

Christie Charitable Funds

UNKNOWN

lead

The Christie NHS Foundation Trust

OTHER